Following on from our "Nanotechnology for Drug Delivery" series of reports we
are turning the focus onto medical diagnostics with our latest report:
"Nanotechnology for Medical Diagnostics"
Nanotech enabled medical diagnostics promise to improve just about everything
that can be improved from a diagnostics point of view: earlier detection of
disease, higher sensitivity, higher accuracy, higher throughput capability,
more results per assay; time saving and cost-effectiveness.
As with our "Nanotechnology for Drug Delivery" series of reports, this
report provides a market numbers for the nanotech enabled medical diagnostic
market between 2000-2010 and a market forecast for the period 2011-2021.
Report Scope
Two sets of data are presented in this report:
The TAM growth for NMBD between 2000-2010;
TAM forecast for NMBD between 2011- 2021.
Both sets of data are segmented into;
TAM (US$ millions, % share, and CAGR) for:
America
Asia (key economies)
Europe (key economies)
RoW (key economies)
Technology type (US$ millions, % share and CAGR) for;
Main Technological Approaches:
Quantum dots (QDs);
Gold nanoparticles;
Cantilevers;
Exosomes;
Nanobiosensors;
Main Technological Applications:
Nanotechnology-based medical and biomedical imaging for diagnostics;
Nanotechnology-based medical devices for diagnostics;
Nanotechnology in Early Disease Detection.
Geographical Scope
The studied regions are:
North America:
USA;
European Union (27):
Germany;
France;
UK;
Other Countries of EU;
Russian Federation
Asia:
India;
Japan;
P. R. China;
South Korea (R. of Korea);
Taiwan;
RoW
Quantifying the Total Addressable Market (TAM) Current
The TAM for nanotech enabled diagnostics is estimated to be 2.439 US$ Billion
(end of 2011).
Nanotechnology applied to medical imaging and gold nanoparticles for diagnosis
were the application and technology respectively, with the highest growth
during the last decade, currently (2011 figures) at:
Medical Imaging: 1.7 Billion US$
Gold Nanoparticles: 959 Million US$
While the US, China and Germany were the countries with the highest growth
currently (2011 figures) at:
North America: 675 Million US$
China: 330 Million US$
Germany: 117 Million US$
Forecast
We forecast the TAM for nanotech enabled diagnostics to reach $53.6B in 2021.
In comparison our report "Nanotechnology for Drug Delivery" forecasts a TAM of
$136B in 2021 for nanotech enabled drug delivery.
In 2021, Asia (China, Japan, South Korea, Taiwan, India combined) tops the
list with the highest TAM, China and India are neck and neck for CAGR.
Of all the technologies studied for this report, exosomes for diagnosis show
the highest CAGR between 2011-2021 while medical imaging remains the highest
growth application of the nanotech enabled diagnostics market in 2021.
Table of Contents
Table of Contents
TABLE OF EXHIBITS
Chapter One
Chapter Two
Chapter Three
Chapter Four
Appendix
Executive Summary
CHAPTER 1
INTRODUCTION AND METHODOLOGY
Report Scope
Scope of Data Analysis
Thematic Scope
Geographical Scope
Methodology
Procurement
Calculation of CAGR
The Nanoscale
Two biological examples that illustrate nanoscale:
CHAPTER 2
INTRODUCTION TO NANOTECHNOLOGY & MEDICINE - OVERVIEW OF NANOTECHNOLOGY
Why is Nanotechnology A Critical Application for Medicine and
Biomedicine?
Why Nanotechnology Is Needed for Medicine and Biomedicine?
WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND
BIOMEDICINE?
The Aim Of Targeting For Detection, Quantification And Characterization
Purposes -
Molecular Recognition in Nanotechnology in Medical And Biomedical
Diagnostics
Reasons Why The Market of Nanotechnology in Medical And Biomedical
Diagnostics
Expanded so Rapidly During The 2000-2010 Decade
Market Drivers For Nanotechnology-Based Medical And Biomedical
Diagnostics
Reasons Why The Market of Nanotechnology in Medical And Biomedical
Diagnostics
Rapidly Expand
Drivers For Synergies Between Nanotechnology in Medical And Biomedical
Diagnostics
And Nanotechnology in Drug Delivery
Increasing Proportion of The Ageing Population
Demand For More Affordable Health Care
Public Health - Ending disease
Demand For More Innovation
Social Responsibility
THE MOST IMPORTANT FIELDS IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE
AND BIOMEDICINE
Nanotechnology in Drug Delivery
Nanotechnology in Medical and Biomedical Diagnostics
Nanotechnology in Regenerative Medicine and Tissue Engineering
Other Applications For Nanomaterials In The Medical And Pharmaceutical
Sector
HOW NANOTECHNOLOGY IS ALREADY HAVING AN IMPACT IN MEDICAL AND BIOMEDICAL
DIAGNOSTICS
Case Study 1 - Diagnosis of head-and-neck cancer from exhaled breath
Case Study 2 - UTSA researchers embracing nanotechnology to accelerate
diagnostics
Case Study 3 - Biocompatible graphene transistor array reads and
records action potentials from electrogenic cells
CHAPTER 3
KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
Nanotoxicity Nanopollution and Nanosafety
Ethical Considerations of Nanotherapies
Delayed Nanoregulation
CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE
AND BIOMEDICINE
Current & Future Challenges of Nanosafety And Risk Management
Current & Future Challenges of Nanoregulation
Current & Future Challenges of Nanomedicine Industry
Current & Future Challenges of Sustained Innovation
Current & Future Challenges of Cooperation
TAM ANALYSIS, WITHOUT SEGMENTATION (2000-2010)
TAM FORECAST , WITHOUT SEGMENTATION (2011-2021)
CHAPTER 4
OVERVIEW OF THE KEY NANOTECHNOLOGIES USED IN MEDICAL AND BIOMEDICAL
DIAGNOSTICS SORTED BY APPLICATIONS
Nanotechnology in Medical and Biomedical Diagnostics: Diagnostics
Nanotechnologies
Quantum Dots
Preparing Quantum Dots
Operation of Quantum Dots
Detection of Quantum Dots
Features And Benefits of Quantum Dots
Disadvantages of Quantum Dots
Application of Quantum Dots to Medical And Biomedical
Nanotechnology-Based
Diagnostics Assays
Prostate-specific antigen assay
Acetylcholine assay
Targeting of membrane protein P-glycoprotein (Pgp) in HeLa cells that
had been
transiently transfected by a plasmid encoding for Pgp
Cellular organelles assay
Cancer detection assay
Imaging assays
Gold Nanoparticles
Application of Gold nanoparticles to Medical And Biomedical Diagnostics
Assays
PSA assay
Alzheimer's disease BCA
BCA as a possible alternative for PCR
Cantilevers
Application of Cantilevers to Medical And Biomedical Diagnostics Assays
Exosomes
Microvesicles Overview
Microvesicles as Mediators of Intercellular Communication
Types of Released Microvesicles
Intracellular Origin of Exosomes
Exosomes as Nanotechnology in medical and biomedical diagnostics
Biomarkers
Nanobiosensors
Medical and Biomedical Imaging
Fluorescent Nanoparticles
In vivo nanoparticle-based near-infrared fluorescence (NIRF) imaging
techniques
Nanobioimaging
Nanotechnology-Based Medical Devices For Diagnostic
Nanopatterned Medical Devices for Diagnostic
Nanoporous Silica Nanochips
Nanowire Biosensors
Micro- And Nanocantilever Arrays
Molecularly Gated Single Electron Transistors
The Most Relevant Technologies in The Key Area of Nanotechnology in
Medical And
Biomedical Diagnostics
STAGE OF DEVELOPMENT OF KEY NANOTECHNOLOGIES USED IN MEDICAL AND
BIOMEDICAL DIAGNOSTICS
Genomics and Proteomics in Nanotechnology in Medical and Biomedical
Diagnosis in
Context of Personalized Medicine
The Potential of The Adoption of Nanotechnology to Medical And
Biomedical Diagnostics
TAM ANALYSIS, WITH SEGMENTATION (2000-2010)
TAM by Country
TAM by Key Technology
TECHNOLOGY ADOPTION ROADMAP
Projected Product Pipeline For Nanotechnology-Based Medical and
Biomedical Diagnostics Market
Projected Product Pipeline For Nanotechnology-Based Medical Devices For
Medical And Biomedical Diagnostics
Projected Product Pipeline For Nanotechnology-Based Medical Devices For
Theranostics
Projected Product Pipeline For Nanotechnology-Based Medical Imaging For
Medical And Biomedical Diagnostics
TAM FORECAST, WITH SEGMENTATION (2011- 2021)
TAM Forecast by Country
TAM forecast by Key Technology
SWOT ANALYSIS (2011-2021 PERIOD)
APPENDIX
List of Figures
CHAPTER ONE
Exhibit 1.1
Formula for the calculation of the Compound Annual Growth Rate (CAGR)
[2].
Exhibit 1.2
Formula for the verification of the calculated values of CAGR
(2011-2021) [2].
Exhibit 1.3
Metres in a nanometre (top), nanometres in a metre (bottom)
CHAPTER TWO
Exhibit 2.1
Illustration of the fact that the periodic table of elements, as we know
it (at meter scale) governed by classic Newtonian laws of physics. However,
when perceived at nanoscale, those elements are governed by the laws of
quantum physics.
Exhibit 2.2
Proportion of the population aged over 65 and over 80 [8].
CHAPTER THREE
Exhibit 3.1
Key barriers to the adoption of nanotechnology in medicine and
biomedicine (Source: Cientifica, Ltd.).
Exhibit 3.2
Specified expected barriers in the development of particular types of
nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
Exhibit 3.3
Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, without segmentation,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.4
Line chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, without segmentation,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.5
Bar chart representing Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, without segmentation,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.6
Table representing the Total Addressable Market, TAM forecast to 2021
(for the 2011- 2021 period), for nanotechnology in medical and biomedical
diagnostics, without segmentation, source: Cientifica (all figures US$
Million Dollars).
Exhibit 3.7
Line chart representing the Total Addressable Market, TAM forecast to
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, without segmentation, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 3.8
Bar chart representing the Total Addressable Market, TAM forecast to
2021 (for the 2011- 2021 period), for nanotechnology in medical and
biomedical diagnostics, without segmentation, source: Cientifica (all
figures US$ Million Dollars).
CHAPTER FOUR
Exhibit 4.1
Summarized comparison of characteristics of quantum dots (QDs),
cantilevers and gold nanoparticles in the scope of the adoption of
nanotechnology to clinical diagnosis [3].
Exhibit 4.2
Schematic diagram representing the general structure of a Quantum dot
(in this case, a typical CdSe/ZnS QD). The coating extremities can change
according to requirements regarding application and biocompatibility (e.g.
mercaptoacetic acid or streptavidin) [3].
Exhibit 4.3
A schematic diagram of a multiplex QD-based assay. Multiple antigens
(Ag) can be labelled through the use of primary antibodies (Ab) conjugated
to QDs with different sizes. One antibody may be biotinylated and detected
with a streptavidin-coated QD. On excitation, QDs will have different
emission maxima based on their sizes [3].
Exhibit 4.4
A summary of toxicity breakthroughs standing on selected quantum dots
studies [3].
Exhibit 4.5
Selected examples of quantum dots-based assays. The presented quantum
dots have different recognition moieties [3].
Exhibit 4.6
Examples of the adoption of nanotechnology to medical and biomedical
diagnosis and a summary of the characteristics of those technologies [3].
Exhibit 4.7
Schematic representation of production and release of exosomes. The
exocytic multivesicular bodies may fuse with membrane and release exosomes
[4].
Exhibit 4.8
Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, all countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.9
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, by world regions
and countries, source: Cientifica (all figures in percentage).
Exhibit 4.10
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics, by world
regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.11
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, by world regions
and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.12
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in medical and biomedical
diagnostics, by world regions and countries, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.13
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in medical and biomedical diagnostics, by
world regions and countries, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.14
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, all world regions
and countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.15
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics, all world
regions and countries studied, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.16
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, European Union
countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.17
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics, European
Union countries studied, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.18
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, European Union
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.19
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in medical and biomedical
diagnostics, European Union countries studied, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.20
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in medical and biomedical diagnostics,
European Union countries studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.21
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, Asian countries
studied, source: Cientifica (all figures in percentage).
Exhibit 4.22
Horizontal bar graph representing the Total Addressable Market, TAM In
2010, for nanotechnology in medical and biomedical diagnostics, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.23
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, Asian countries
studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.24
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010), for nanotechnology in medical and biomedical
diagnostics, Asian countries studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.25
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010), for nanotechnology in medical and biomedical diagnostics, Asian
countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.26
Table representing the Total Addressable Market, TAM (2000-2010), for
nanotechnology in medical and biomedical diagnostics, all most relevant key
technologies, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.27
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, all key
technologies studied, source: Cientifica (all figures in percentage).
Exhibit 4.28
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics, all key
technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.29
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, all key
technologies studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.30
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical
diagnostics, all key technologies studied, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.31
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in medical and biomedical diagnostics, all
key technologies studied, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.32
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, technological
approaches as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.33
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics,
technological approaches as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.34
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, technological
approaches as a whole, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.35
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical
diagnostics, technological approaches as a whole, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.36
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in medical and biomedical diagnostics,
technological approaches as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.37
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, technological
applications as a whole, source: Cientifica (all figures in percentage).
Exhibit 4.38
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics,
technological applications as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.39
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, technological
applications as a whole, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.40
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical
diagnostics, technological applications as a whole, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.41
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in medical and biomedical diagnostics,
technological applications as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.42
3-D pie chart representing the Total Addressable Market, TAM in 2010,
for nanotechnology in medical and biomedical diagnostics, impact of early
disease detection, source: Cientifica (all figures in percentage).
Exhibit 4.43
Horizontal bar graph representing the Total Addressable Market, TAM in
2010, for nanotechnology in medical and biomedical diagnostics, impact of
early disease detection, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.44
Line chart representing the Total Addressable Market, TAM (2000-2010),
for nanotechnology in medical and biomedical diagnostics, impact of early
disease detection, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.45
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM (2000- 2010) , for nanotechnology in medical and biomedical
diagnostics, impact of early disease detection, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.46
3-D stacked area chart representing the Total Addressable Market, TAM
(2000-2010) , for nanotechnology in medical and biomedical diagnostics,
impact of early disease detection, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.47
Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011- 2021 period), for nanotechnology in medical and biomedical
diagnostics, by world regions / countries, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.48
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, by world
regions, source: Cientifica (all figures in percentage).
Exhibit 4.49
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.50
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, by world regions, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.51
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, by world regions, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 4.52
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, by world regions, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.53
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, by all world
regions / countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.54
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
by all world regions / countries studied, source: Cientifica (all figures
US$ Million Dollars).
Exhibit 4.55
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, by all world regions / countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.56
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, by all world regions / countries
studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.57
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, by all world regions / countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.58
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, European
Union countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.59
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
European Union countries studied, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.60
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, European Union countries studied, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 4.61
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, European Union countries studied,
source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.62
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, European Union countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.63
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, Asian
countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.64
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
Asian countries studied, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.65
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diag ostics, Asian countries studied, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.66
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, Asian countries studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.67
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and bio edical diagnostics, Asian countries studied, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.68
Table representing the Total Addressable Market, TAM forecast by 2021
(for the 2011- 2021 period), for nanotechnology in medical and biomedical
diagnostcs, all most relevant key technologies, source: Cientifica (all
figures US$ Million Dollars).
Exhibit 4.69
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, all key
technologies studied, source: Cientifica (all figures in percentage).
Exhibit 4.70
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
all key technologies studied, source: Cientifica (all figures in percentage).
Exhibit 4.71
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, all key technologies studied, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 4.72
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, all key technologies studied, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.73
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, all key technologies studied, source: Cientifica
(all figures US$ Million Dollars).
Exhibit 4.74
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics,
technological approaches as a whole, source: Cientifica (all figures in
percentage).
Exhibit 4.75
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
technological approaches as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.76
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, technological approaches as a whole, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.77
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, technological approaches as a whole,
source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.78
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, technological approaches as a whole, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.79
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics,
technological applications as a whole, source: Cientifica (all figures in
percentage).
Exhibit 4.80
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
technological applications as a whole, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.81
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, technological applications as a whole, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.82
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, technological applications as a
whole, source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.83
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, technological applications as a whole, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.84
3-D pie chart representing the Total Addressable Market, TAM forecast in
2021, for nanotechnology in medical and biomedical diagnostics, impact of
early disease detection, source: Cientifica (all figures in percentage).
Exhibit 4.85
Horizontal bar graph representing the Total Addressable Market, TAM
forecast in 2021, for nanotechnology in medical and biomedical diagnostics,
impact of early disease detection, source: Cientifica (all figures US$
Million Dollars).
Exhibit 4.86
Line chart representing the Total Addressable Market, TAM forecast by
2021 (for the 2011-2021 period), for nanotechnology in medical and
biomedical diagnostics, impact of early disease detection, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.87
3-D stacked vertical bar graph representing the Total Addressable
Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology
in medical and biomedical diagnostics, impact of early disease detection,
source: Cientifica (all figures US$ Million
Dollars).
Exhibit 4.88
3-D stacked area chart representing the Total Addressable Market, TAM
forecast by 2021 (for the 2011-2021 period), for nanotechnology in medical
and biomedical diagnostics, impact of early disease detection, source:
Cientifica (all figures US$ Million Dollars).
Exhibit 4.89
SWOT analysis to evaluate the strengths, weaknesses, opportunities and
threats involved in nanotechnology in medical and biomedical diagnostics, in
the scope of the technology adoption roadmap (during the 2011-2021 period).
APPENDIX
Exhibit A.1
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: North America; country: USA.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.2
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
Germany.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.3
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country:
France.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.4
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
Exhibit A.5
Table of the organizations with publishing activity in PubMed
periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug
Delivery. Country: Russian Federation.
Organizations are ordered alphabetically (increasing order).
Exhibit A.6
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.7
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: India.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.8
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.9
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.10
Table of the top 20 organizations showing the highest publishing
activity in PubMed periodicals (2000-2010), based on PubMed, for
Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea
(Republic of Korea).
Organizations are ordered first by descending order of total articles
published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.11
Table of the organizations with publishing activity in PubMed
periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug
Delivery. Asia; country: Taiwan.
Nanotechnology for Medical Diagnostics 2012 published by Cientifica Ltd in March 13, 2012. This report price starts from US $ 4000.
